Effect of APOE genotype on synaptic proteins in earlier adult life

Lindsey I. Sinclair*, Seth Love

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)
348 Downloads (Pure)


Background: Possession of APOE ϵ4 is a strong risk factor for late-onset Alzheimer's disease and is associated with loss of synaptic proteins in the elderly even in the absence of Alzheimer's disease. Objective: We hypothesized that ϵ4 allele possession in non-demented adults aged under-75 would also be associated with alterations in the levels of synaptic proteins. Methods: We measured synaptophysin, PSD95, drebrin, SNAP-25, and septin 7 by ELISA in hippocampus and superior temporal gyrus from 103 adults aged <75 without dementia. Corresponding gene expression was measured by RT-PCR. Results: There was no evidence that ϵ4 affected levels of the proteins measured. Instead we found an increase in post-synaptic proteins in the hippocampi of those with an ϵ32 genotype. The evidence was strongest for drebrin (p = 0.011). There was some evidence of increased synaptic protein gene expression in ϵ4 carriers. Conclusions: People with an APOE ϵ32 genotype have a reduced risk of Alzheimer's disease. It may be relevant that they have a higher level of post-synaptic proteins in the hippocampus even in earlier adulthood.

Original languageEnglish
Pages (from-to)1123-1137
Number of pages15
JournalJournal of Alzheimer's Disease
Issue number3
Publication statusPublished - 29 Jul 2017

Structured keywords

  • Dementia Research Group


  • Alzheimer's disease
  • APOE
  • dementia
  • drebrin
  • genetics
  • postmortem tissue
  • PSD-95
  • synaptic proteins
  • synaptophysin


Dive into the research topics of 'Effect of APOE genotype on synaptic proteins in earlier adult life'. Together they form a unique fingerprint.

Cite this